Fundsmith is a London-based investment management company, founded in 2010 by Terry Smith. As of 31 December 2017, Fundsmith managed more than £14bn in assets.
Fundsmith operates a buy-and-hold investment strategy with a portfolio based on a small number of stocks, chosen through in-house analysis of company fundamentals, eschewing other techniques such as momentum investing, market timing or shorting.
Fundsmith operates two main investment vehicles: Fundsmith Equity Fund, an open-ended investment company (OEIC); and the closed-ended Fundsmith Emerging Equities Trust, which is a listed investment trust.
Unilever has faced a tumultuous few weeks as news of its failed £50bn bid to buy GlaxoSmithKline’s consumer health unit came to light along with job cuts, scathing remarks from star fund managers and an activist investor taking a position.
Highlights strong performance of Fundsmith Equity fund
LGIM second for retail sales
BG tops net retail sales chart with £2bn
Rated as ‘Alpha Managers’ consistently for at least seven years
'Most' of the business will remain in current employees' hands
ESG flows boost Liontrust and Rathbones